Meredith Sellers Pelster/LinkedIn
May 31, 2025, 22:17
Meredith Sellers Pelster Discusses Breakwater Study Insights for Colorectal Patients with BRAF V600E Mutation
Sarah Cannon Research Institute shared a post on LinkedIn:
“Meredith Sellers Pelster shares her insights on the meaningful results of the Breakwater study for colorectal patients with BRAF V600E Mutation with Endpoints News.”
Quoting Meredith Sellers Pelster‘s post:
“Honored to share my thoughts with Endpoints on the meaningful results of the Breakwater study for colorectal cancer patients. The patient population with BRAF V600E mutation has historically had a poor prognosis, and we are excited about the impact this advancement can have on patients who need more treatment options.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 21, 2025, 23:33
Aug 21, 2025, 20:00
Aug 21, 2025, 15:59